METRONIDAZOLE VAGINAL GEL, 1.3 %

METRONIDAZOLE VAGINAL GEL, 1.3 % was reported 26 times

METRONIDAZOLE VAGINAL GEL, 1.3 % is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VULVOVAGINAL EXFOLIATION 1 0.0192
1 SWEAT DISCOLOURATION 1 0.0058
2 BACTERIAL VULVOVAGINITIS 1 0.0035
3 BACTERIAL VAGINOSIS 3 0.0019
4 VAGINAL ODOUR 2 0.0016
5 GLUTEN SENSITIVITY 1 0.0007
6 VULVOVAGINAL DISCOMFORT 2 0.0005
7 VULVOVAGINAL DRYNESS 1 0.0003
8 VAGINAL DISCHARGE 3 0.0003
9 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
10 DYSPAREUNIA 1 0.0002
11 VULVOVAGINAL PRURITUS 1 0.0002
12 SYMPTOM RECURRENCE 1 0.0002
13 VULVOVAGINAL BURNING SENSATION 1 0.0002
14 COELIAC DISEASE 1 0.0001
15 VAGINAL HAEMORRHAGE 3 0.0001
16 THIRST 1 0.0001
17 DRY MOUTH 4 0.0000
18 APPLICATION SITE PAIN 1 0.0000
19 MUSCLE TWITCHING 1 0.0000
20 DISEASE RECURRENCE 2 0.0000
21 DYSGEUSIA 3 0.0000
22 RASH GENERALISED 1 0.0000
23 EXPIRED PRODUCT ADMINISTERED 1 0.0000
24 FUNGAL INFECTION 1 0.0000
25 BURNING SENSATION 2 0.0000
26 ABORTION SPONTANEOUS 1 0.0000
27 TREATMENT NONCOMPLIANCE 1 0.0000
28 PRODUCT SUBSTITUTION ISSUE 1 0.0000
29 IRRITABILITY 1 0.0000
30 ACNE 1 0.0000
31 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
32 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
33 ADVERSE EVENT 1 0.0000
34 SWELLING 1 0.0000
35 NEUROPATHY PERIPHERAL 1 0.0000
36 DYSPEPSIA 1 0.0000
37 ILLNESS 1 0.0000
38 ABDOMINAL DISTENSION 1 0.0000
39 CONSTIPATION 2 0.0000
40 INSOMNIA 2 0.0000
41 VISION BLURRED 1 0.0000
42 ABDOMINAL DISCOMFORT 1 0.0000
43 MUSCLE SPASMS 1 0.0000
44 PRURITUS 2 0.0000
45 ABDOMINAL PAIN 1 0.0000
46 FEELING ABNORMAL 1 0.0000
47 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
48 NAUSEA 3 0.0000
49 ANXIETY 1 0.0000
50 ASTHENIA 1 0.0000
51 RASH 1 0.0000
52 MALAISE 1 0.0000
53 HEADACHE 1 0.0000
54 DIARRHOEA 1 0.0000
55 DRUG INEFFECTIVE 1 0.0000